We are a biopharmaceutical company engaged in the development and commercialization of premium cannabinoid-based nutraceuticals and pharmaceuticals
Our Consumer Facing Bio-Cannabis Product Line
CBD | CBD+THC | THC
Capsules & Tablets • Bulk Powder • Stick Packs • Beverages • Water Soluble Oral Solutions
Lotions, Creams & Gels • Pet Food Additives
Welcome to Our Family of Brands
Pivot has a holistic approach to business. Our three divisions are structured to efficiently and quickly achieve business goals through procurement, manufacturing and supply & distribution
Pivot Pharmaceuticals is Poised to Become a Strategic Winner in the Exploding Cannabis Market
With legislation changing rapidly, Pivot is positioned to take advantage of the rapid growth in the Canadian, Californian and International Markets. The legal international cannabis market is expected to grow more than 1000 percent within the next 10 years, reaching $140 billion by 2027*. Our strategy is threefold:
Procurement • Manufacturing • Supply & Distribution
Our Markets
California • Colorado • Canada • Europe
Our Technologies
Pivot has acquired worldwide rights for four proprietary drug delivery technologies for the delivery and commercialization of cannabinoid, cannabidiol and tetrahydrocannabinol-based products
Thrudermic™
TRANSDERMAL NANOTECHNOLOGY
FOR CANNABINOIDS
1% CBD NANO-PARTICULATE CREAM
READY FOR COMMERCIALIZATION
Solmic™
MICELLE ORAL DRUG DELIVERY TECHNOLOGY
FOR CANNABINOIDS
1% CBD >99% PURE
READY FOR COMMERCIALIZATON
BiPhasix™
TOPICAL DELIVERY TECHNOLOGY
FOR CANNABINOIDS
1% CBD BIPHASIX CREAM
READY FOR COMMERCIALIZATION
RTIC™
TECHNOLOGY FOR TRANFORMATION OF
CANNABIS OIL TO POWDER
READY TO INFUSE CANNABIS POWDER FOR USE IN CAPSULES, STICK PACKS, BULK POWDER, BEVERAGES, BAKED GOODS
COMING SOON
TriVair™
NASAL AND PULMONARY BREATH-PROPELLED,
MULTI-DIRECTIONAL DRUG DELIVERY SYSTEMS™
RTIC Cannabis Powder Combined with the TriVair™ Delivery System
Each technology platform allows Pivot to produce multiple products
Investor Overview
Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Our shares are publicly-traded on the CNX under the ticker symbol “PVOT” and on the OTCQB under the ticker symbol “PVOTF”
Our Leadership Team
Pivot has assembled a highly experienced management team that has clinical, commercial, product development and financial experience
Email:
Mailing Address:
#300-1275 West 6th Avenue Vancouver, BC Canada, V6H 1A6
Investor Relations:
Virtus Advisory Group Inc.
1 First Canadian Place
100 King West, Suite 5600
Toronto, ON, M5X1C9
Tel:416-644-5081 | Fax:416-644-8801
E: ccohen@virtusadvisory.com
Contact Us
